CollPlant Biotechnologies (CLGN) EV to CFO (2018 - 2025)

CollPlant Biotechnologies (CLGN) has reported EV to CFO for 8 consecutive years, with 1.42 the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, EV to CFO fell 38.92% year-over-year to 1.42; the trailing twelve-month figure through Dec 2025 stood at 0.35 (down 37.75% YoY), and the FY2025 full-year result was 0.44, down 22.56% from the prior year.
• EV to CFO eased to 1.42 in Q4 2025 per CLGN's latest filing, from 2.0 in the prior quarter.
• Across five years, EV to CFO topped out at 23.78 in Q3 2022 and bottomed at 3.39 in Q3 2023.
• Historically, EV to CFO has averaged 5.6 across 5 years, with a median of 3.43 in 2024.
• The widest YoY moves for EV to CFO: up 4080.34% in 2021, down 522.09% in 2021.
• Over 5 years, EV to CFO stood at 1.84 in 2021, then surged by 180.51% to 1.48 in 2022, then jumped by 462.92% to 8.36 in 2023, then sank by 72.25% to 2.32 in 2024, then sank by 38.92% to 1.42 in 2025.
• According to Business Quant data, EV to CFO over the past three periods registered 1.42, 2.0, and 4.16 for Q4 2025, Q3 2025, and Q2 2025 respectively.